Evaluation of Decompression and Interlaminar Stabilization Compared with Decompression and Fusion for the Treatment of Lumbar Spinal Stenosis: 5-year Follow-up of a Prospective, Randomized, Controlled Trial.

可视模拟标度 背痛 脊柱融合术 腰痛 狭窄
作者
Michael J. Musacchio,Carl Lauryssen,Reginald J. Davis,Hyun W. Bae,John H. Peloza,Richard D. Guyer,Jack E. Zigler,Donna D. Ohnmeiss,Scott P. Leary
出处
期刊:The International Journal of Spine Surgery [CIG Media Group]
卷期号:10: 6-6 被引量:24
标识
DOI:10.14444/3006
摘要

Introduction If nonoperative treatment for lumbar stenosis fails, surgery may be considered. This traditionally includes decompression often combined with fusion. Desire for less extensive surgery led to developing new techniques and implants, including an interlaminar device designed with the goal of providing segmental stability without fusion, following decompression. The purpose of this study was to investigate 5-year outcomes associated with an interlaminar device. Methods This prospective, randomized, controlled trial was conducted at 21 centers. Patients with moderate to severe lumbar stenosis at one or two contiguous levels and up to Grade I spondylolisthesis were randomized (2:1 ratio) to decompression and interlaminar stabilization (D+ILS; n=215) using the coflex® Interlaminar Stabilization® device (Paradigm Spine, LLC) or decompression and fusion with pedicle screws (D+PS; n=107). Clinical evaluations were made preoperatively and at 6 weeks and 3, 6, 12, 18, 24, 36, 48, and 60 months postoperatively. Overall Food and Drug Administration success criteria required that a patient meet 4 criteria: 1) >15 point improvement in Oswestry Disability Index (ODI) score; 2) no reoperation, revision, removal, or supplemental fixation; 3) no major device-related complication; and 4) no epidural steroid injection after surgery. Results At 5 years, 50.3% of D+ILS vs. 44% of D+PS patients (p>0.35) met the composite success criteria. Reoperation/revision rates were similar in the two groups (16.3% vs. 17.8%; p >0.90). Both groups had statistically significant improvement through 60 months in ODI scores with 80.6% of D+ILS patients and 73.2% of D+PS patients demonstrating >15 point improvement (p>0.30). VAS, SF-12, and ZCQ scores followed a similar pattern of maintained significant improvement throughout follow-up. On the SF-12 and ZCQ, D+ILS group scores were statistically significantly better during early follow-up compared to D+PS. In the D+ILS group, foraminal height, disc space height, and range of motion at the index level were maintained through 5 years. Conclusion Both treatment groups achieved and maintained statistically significant improvements on multiple outcome assessments throughout 5-year follow-up. On some clinical measures, there were statistically significant differences during early follow-up favoring D+ILS. At no point were there significant differences favoring D+PS. Results of this 5-year follow-up study demonstrate that decompression and interlaminar stabilization with coflex is a viable alternative to traditional decompression and fusion in the treatment of patients with moderate to severe stenosis at one or two lumbar levels. Level of Evidence and Ethical Statements This is a Level I study. Institutional approval was received at each of the sites participating in the trial. Each patient gave informed consent to participate in the trial.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
雯雯完成签到,获得积分10
刚刚
乐乐应助伶俐冰之采纳,获得10
刚刚
南茶北暖完成签到,获得积分10
1秒前
1秒前
成就的曼凡完成签到,获得积分10
2秒前
2秒前
doou完成签到,获得积分10
2秒前
奥沙利楠完成签到,获得积分10
2秒前
无心的钢笔完成签到 ,获得积分10
2秒前
眼睛大的莫英完成签到 ,获得积分10
3秒前
Jasper应助丹牛采纳,获得10
3秒前
舒服的初蓝完成签到,获得积分10
3秒前
3秒前
ehsl完成签到,获得积分10
4秒前
XYNW完成签到,获得积分10
4秒前
丫丫完成签到,获得积分10
4秒前
4秒前
han发布了新的文献求助10
5秒前
bushi完成签到,获得积分10
5秒前
爱吃泡芙完成签到,获得积分10
6秒前
PFD000发布了新的文献求助10
6秒前
CocoGabrielle完成签到,获得积分10
6秒前
丘离完成签到 ,获得积分10
7秒前
独特的灭龙完成签到,获得积分10
7秒前
高高诗柳完成签到 ,获得积分10
7秒前
weiweiwu12完成签到,获得积分10
8秒前
小灰灰完成签到,获得积分0
8秒前
sadhimmel3完成签到,获得积分10
8秒前
8秒前
nuture发布了新的文献求助10
9秒前
江江好完成签到,获得积分10
9秒前
生动的访琴完成签到,获得积分10
9秒前
竞鹤完成签到,获得积分10
10秒前
123123完成签到,获得积分10
10秒前
zy应助yurinsy采纳,获得20
11秒前
鲨鱼也蛀牙完成签到,获得积分10
11秒前
wangyi完成签到,获得积分10
11秒前
David123完成签到,获得积分10
11秒前
VC发布了新的文献求助10
12秒前
bkagyin应助李亚男采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
The Cambridge History of China: Volume 4, Sui and T'ang China, 589–906 AD, Part Two 1500
Cowries - A Guide to the Gastropod Family Cypraeidae 1200
Quality by Design - An Indispensable Approach to Accelerate Biopharmaceutical Product Development 800
Signals, Systems, and Signal Processing 610
Research Methods for Applied Linguistics 500
A Social and Cultural History of the Hellenistic World 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6394926
求助须知:如何正确求助?哪些是违规求助? 8210017
关于积分的说明 17385475
捐赠科研通 5448187
什么是DOI,文献DOI怎么找? 2880091
邀请新用户注册赠送积分活动 1856615
关于科研通互助平台的介绍 1699307